Ibrutinib treatment alters enhancer activity patterns in Chronic Lymphocytic Leukemia

A. Lambe; N. Papakonstantinou; M. Gounari; K. Stamatopoulos; E. Kostareli

doi:10.1097/01.hs9.0000562780.40613.ef

Ibrutinib treatment alters enhancer activity patterns in Chronic Lymphocytic Leukemia

A. Lambe, N. Papakonstantinou, M. Gounari, K. Stamatopoulos, E. Kostareli^*

^*Corresponding author for this work

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	508
Journal	HemaSphere
Volume	3
Issue number	Suppl 1
DOIs	https://doi.org/10.1097/01.hs9.0000562780.40613.ef
Publication status	Published - Jun 2019
Event	24th Congress of the European Hematology Association (EHA) - Amsterdam, Netherlands Duration: 13 Jun 2019 → 16 Jun 2019

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Hematology

Access to Document

10.1097/01.hs9.0000562780.40613.efLicence: Unspecified

Cite this

@article{88eec55c133d48a2be38375c7a4f2f87,

title = "Ibrutinib treatment alters enhancer activity patterns in Chronic Lymphocytic Leukemia",

author = "A. Lambe and N. Papakonstantinou and M. Gounari and K. Stamatopoulos and E. Kostareli",

year = "2019",

month = jun,

doi = "10.1097/01.hs9.0000562780.40613.ef",

language = "English",

volume = "3",

pages = "508",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "Suppl 1",

note = "24th Congress of the European Hematology Association (EHA), 24th EHA Congress ; Conference date: 13-06-2019 Through 16-06-2019",

}

TY - JOUR

T1 - Ibrutinib treatment alters enhancer activity patterns in Chronic Lymphocytic Leukemia

AU - Lambe, A.

AU - Papakonstantinou, N.

AU - Gounari, M.

AU - Stamatopoulos, K.

AU - Kostareli, E.

PY - 2019/6

Y1 - 2019/6

UR - http://www.mendeley.com/research/ibrutinib-treatment-alters-enhancer-activity-patterns-chronic-lymphocytic-leukemia

U2 - 10.1097/01.hs9.0000562780.40613.ef

DO - 10.1097/01.hs9.0000562780.40613.ef

M3 - Meeting abstract

VL - 3

SP - 508

JO - HemaSphere

JF - HemaSphere

SN - 2572-9241

IS - Suppl 1

T2 - 24th Congress of the European Hematology Association (EHA)

Y2 - 13 June 2019 through 16 June 2019

ER -

Ibrutinib treatment alters enhancer activity patterns in Chronic Lymphocytic Leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this